PRVANasdaqServices-Health ServicesFiscal year ends December 31
Privia Health Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$22.44−0.08 (-0.36%)
Close on Oct 19, 2026
- Market cap
- $2.96B
- P/E (TTM)
- 106.9
- Dividend yield
- –
Share price
−$3.09 (−12.10%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Privia Health Group, Inc. grew revenue 24.1% to $2.36B over the twelve months to Jun 30, 2026. Operating income rose 128.8% to $44.88M, moving the operating margin from 1.0% to 1.9%.
Revenue
$2.36B
+24.1% vs. a year earlier
Operating income
$44.88M
+128.8% vs. a year earlier
EPS, diluted
$0.21
+90.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.96B
- P/E ratio
- 106.9
- Price to sales
- 1.25
- Price to book
- 3.78
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.36B
- Net income
- $28.12M
- EPS, diluted
- $0.21
- Book value per share
- $5.93
- Diluted shares
- 132M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$2.36B+24.1% YoY
Operating income
$44.88M+128.8% YoY
Net income
$28.12M+89.5% YoY
EPS, diluted
$0.21+90.9% YoY
Free cash flow
–
Reported periodTrailing twelve months